ARQT
ARQT
US03969K1088
Arcutis Biotherapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.34B EUR
3.29B EUR
2.95B EUR
3.58B EUR
Enterprise Value
2.95B EUR
3.37B EUR
3.03B EUR
3.65B EUR
Valuation Multiples
Trailing P/E
120.82x
115.47x
--
401.57x
Forward P/E
19.54x
--
--
--
Price to Sales
7.2x
7.1x
7.09x
11.55x
Price to Book
15.14x
14.93x
15.53x
18.9x
EV/Revenue
6.37x
7.27x
7.28x
11.77x
EV/EBITDA
80.92x
74.31x
211.19x
177.33x
Price to FCF (P/FCF)
154.06x
84.11x
174.15x
244.03x
EV/FCF
136.21x
86.15x
178.88x
248.89x
FCF Yield
0.65%
1.19%
0.57%
0.41%
ende